Home › NDC Lookup › Ingredients › Loratadine › 70677-1043-01
⚪image loading
(from DailyMed)

foster and thrive childrens allergy relief loratadine 5 mg Tablet, Chewable — NDC 70677-1043-1 (Billing 70677-1043-01)

by Strategic Sourcing Services LLC · 30 BLISTER PACK in 1 CARTON / 1 TABLET, CHEWABLE in 1 BLISTER PACK

This is a package of foster and thrive childrens allergy relief loratadine 5 mg Tablet, Chewable from Strategic Sourcing Services LLC, marketed since Oct 2023 and currently FDA-listed; retail pharmacies pay about $0.5212 per unit (NADAC). It is this product's only package size.

NDC 70677-1043-01
🏷️ FDA NDC (as labeled) 70677-1043-1 billing pads the package segment with a zero
OTC Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 70677-1043-1
Product NDC 70677-1043
11-digit billing NDC 70677104301
NCPDP billing unit EA — each (per item)
RxCUI 665078
UNII 7AJO3BO7QN
Application # ANDA210033
SPL Set ID 5ac59de8-46ad-4731-8f98-167fb5f8b089
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2023-10-30
Route ORAL
Dosage form TABLET, CHEWABLE
Substance LORATADINE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 41550030000520
GCN Seq No 062340
GCN 98118
HICL code 007605
Ingredient (HICL) Loratadine
HIC1 code Z
Therapeutic class — broad (HIC1) Body As A Whole
HIC2 code Z2
Therapeutic class — intermediate (HIC2) Antihistamines, Antiserotonins, Immunosuppressants
HIC3 code Z2Q
Therapeutic class — specific (HIC3) Antihistamines - 2Nd Generation
AHFS code 04:08.00.00
AHFS class Second Generation Antihistamines
FDB label name FT CHILD ALLERGY RLF 5 MG CHEW
FDB brand name Children's Allergy Relief
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 062340
  • GCN: 98118
  • GPI-14 (Medi-Span): 41550030000520
  • HICL (First Databank): 007605
  • AHFS class code: 04:08.00.00
  • RxCUI (RxNorm): 665078
Why two NDCs? The FDA registers this code as 70677-1043-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70677-1043-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Other antihistamines for systemic use class.

Drug family (ATC) Other antihistamines for systemic use
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name FT CHILD ALLERGY RLF 5 MG CHEW Ingredient Loratadine
📗 Our plain-language guide HelloPharmacist
  • It temporarily relieves symptoms of hay fever and other upper respiratory allergies. That means runny nose, sneezing, itchy, watery eyes, and an itchy nose or throat.
  • It is taken by mouth, generally once a day. Follow the directions on your specific product. Chewable tablets should be chewed or crushed completely, and liquids should be measured...
  • No. Do not take more than directed. Taking more than directed may cause drowsiness. If you think you took too much, get medical help or call Poison Control right away.
  • Can I take extra if my allergies are bad?
📖 Read our full Loratadine guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.521 $15.64 / 30 tablet
Medicaid paysCMS SDUD · 12 mo $0.5926 $17.78 / 30 tablet
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Dec 2025 Mar 2026 Jun 2026 Sep 2026 $0.530 $0.494
▲ Up 6% over the last 10 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
70677-1043-01 You're viewing this Main listing 30 BLISTER PACK in 1 CARTON / 1 TABLET, CHEWABLE in 1 BLISTER PACK 2023-10-30 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Loratadine 5 mg 51660-0753-31 Ohm 10 tablets $0.404 — FDA listed save 22%
Childrens Loratadine 5 mg 51660-0754-31 Ohm 10 tablets $0.511 — FDA listed save 2%
Dye-Free Childrens Loratadine 5 mg 51660-0112-31 Ohm 10 tablets $0.521 — Availability likely —
foster and thrive childrens allergy relief 5 mgthis 70677-1043-01 Strategic 1 tablet $0.521 — Availability likely —
good sense childrens allergy relief 5 mg 00113-1019-39 L. 1 tablet — — Discontinued —
Loratadine 5 mg 00363-0752-30 WALGREEN 10 tablets — — FDA listed —
Wal-itin 5 mg 00363-0754-30 Walgreens 10 tablets — — FDA listed —
Loratadine 5 mg 00363-9985-30 WALGREENS 10 tablets — — FDA listed —
Wal-itin 5 mg 00363-9995-30 WALGREENS 10 tablets — — FDA listed —
Claritin 5 mg 11523-0104-01 Bayer 10 tablets — — FDA listed —
Claritin Chewable Grape and Bubblegum 11523-0123-01 Bayer 1 kit — — FDA listed —
Claritin 5 mg 11523-4328-01 Bayer 10 tablets — — FDA listed —
Claritin 5 mg 11523-4330-01 Bayer 10 tablets — — FDA listed —
Claritin 5 mg 11523-4331-01 Bayer 10 tablets — — FDA listed —
Dye-Free Childrens Loratadine 5 mg 11673-0111-30 UP 10 tablets — — FDA listed —
Dye-Free Childrens Loratadine 5 mg 11673-0115-30 UP 10 tablets — — FDA listed —
Childrens Loratadine 5 mg 11673-0310-30 TARGET 10 tablets — — FDA listed —
Childrens Allergy 5 mg 11673-0996-30 TARGET 10 tablets — — FDA listed —
Childrens Loratadine 5 mg 11673-0997-30 TARGET 10 tablets — — FDA listed —
childrens allergy relief 5 mg 11822-0801-01 Rite 1 tablet — — FDA listed —
Loratadine 5 mg 11822-7240-00 Rite 30 tablets — — FDA listed —
Dye-Free Childrens Loratadine 5 mg 11822-8329-07 RITE 10 tablets — — FDA listed —
Dye-Free Childrens Loratadine 5 mg 11822-9999-03 RITE 10 tablets — — FDA listed —
Dye-Free Childrens Loratadine 5 mg 21130-0646-20 SAFEWAY 10 tablets — — FDA listed —
Childrens Loratadine 5 mg 21130-0963-20 SAFEWAY 10 tablets — — FDA listed —
Childrens Loratadine 5 mg 21130-0999-20 SAFEWAY 10 tablets — — FDA listed —
Loratadine 5 mg 30142-0565-30 KROGER 10 tablets — — FDA listed —
Loratadine 5 mg 30142-0984-30 KROGER 10 tablets — — FDA listed —
Loratadine 5 mg 30142-0996-30 KROGER 10 tablets — — FDA listed —
topcare childrens allergy relief 5 mg 36800-0363-39 Topco 1 tablet — — FDA listed —
Childrens Allergy Relief 5 mg 37808-0506-39 H 1 tablet — — FDA listed —
Equaline Childrens Allergy Relief 5 mg 41163-0364-01 United 1 tablet — — FDA listed —
childrens allergy relief 5 mg 41250-0629-39 Meijer 1 tablet — — FDA listed —
careone childrens allergy relief 5 mg 41520-0716-01 American 1 tablet — — FDA listed —
Childrens Loratadine 5 mg 46122-0550-60 Amerisource 10 tablets — — Discontinued —
Loratadine 5 mg 49035-0953-30 Wal-Mart 10 tablets — — FDA listed —
childrens allergy relief 5 mg 51316-0133-52 CVS 1 tablet — — FDA listed —
Dye-Free Childrens Loratadine 5 mg 51316-0821-20 CVS 10 tablets — — FDA listed —
Dye-Free Childrens Loratadine 5 mg 51660-0726-30 Ohm 10 tablets — — FDA listed —
dg health childrens allergy relief 5 mg 55910-0807-52 Dolgencorp, 1 tablet — — FDA listed —
Dye-Free Childrens Loratadine 5 mg 56062-0900-20 PUBLIX 10 tablets — — FDA listed —
Dye-Free Childrens Loratadine 5 mg 56062-0921-20 PUBLIX 10 tablets — — FDA listed —
Loratadine 5 mg 56062-0990-20 PUBLIX 10 tablets — — FDA listed —
Loratadine 5 mg 68016-0053-10 Premier 10 tablets — — FDA listed —
Berkley and Jensen Childrens Allergy Relief 5 mg 68391-0301-49 BJWC 1 tablet — — FDA listed —
Dye-Free Childrens Loratadine 5 mg 69842-0894-30 CVS 10 tablets — — FDA listed —
Dye-Free Childrens Loratadine 5 mg 69842-0895-20 CVS 10 tablets — — FDA listed —
Childrens Loratadine 5 mg 69842-0953-20 CVS 10 tablets — — FDA listed —
Childrens Loratadine 5 mg 69842-0954-30 CVS 10 tablets — — FDA listed —
Basic Care Childrens Allergy Relief 5 mg 72288-0901-01 Amazon.com 1 tablet — — FDA listed —
Curist Childrens Allergy Relief 5 mg 72559-0031-43 Little 10 tablets — — FDA listed —
Dye-Free Childrens Loratadine 5 mg 79903-0008-30 WAL-MART 10 tablets — — FDA listed —
Dye-Free Childrens Loratadine 5 mg 79903-0330-30 WAL-MART 10 tablets — — FDA listed —
Loratadine 5 mg 00363-9994-30 WALGREENS 10 tablets — — FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2023
On the market since
Oct 2023
📍
2026
Currently FDA-listed
3 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerStrategic Sourcing Services LLC
Application holderPERRIGO PHARMA INTERNATIONAL DESIGNATED ACTIVITY CO
FDA applicationANDA210033 (ANDA)
Labeler code70677
First marketedOct 2023
Product typeHuman Otc Drug
Portfolio316 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 30 words ▾

Uses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: • runny nose • itchy, watery eyes • sneezing • itching of the nose or throat

⏱️ Dosage and Administration 66 words ▾

Directions • chew or crush tablets completely before swallowing adults and children 6 years and over chew 2 tablets daily; not more than 2 tablets in 24 hours children 2 to under 6 years of age chew 1 tablet daily; not more than 1 tablet in 24 hours children under 2 years of age ask a doctor consumers with liver or kidney disease ask a doctor

⚠️ Warnings 110 words ▾

Warnings Do not use if you have ever had an allergic reaction to this product or any of its ingredients Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose. When using this product do not take more than directed.

Taking more than directed may cause drowsiness. Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.

If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

📦 Storage and Handling 36 words ▾

Other information • phenylketonurics: contains phenylalanine 1.4 mg per tablet • do not use if blister unit is broken or torn • store between 20 ° to 25 ° C (68 ° to 77 ° F)

🧪 Active Ingredient 8 words ▾

Active ingredient (in each tablet) Loratadine 5 mg

🧪 Inactive Ingredients 29 words ▾

Inactive ingredients artificial grape flavor, aspartame, colloidal silicon dioxide, D&C red #27 aluminum lake, FD&C blue #2 aluminum lake, magnesium stearate, mannitol, microcrystalline cellulose, sodium starch glycolate, stearic acid

🎯 Purpose 2 words ▾

Purpose Antihistamine

📄 Do Not Use 19 words ▾

Do not use if you have ever had an allergic reaction to this product or any of its ingredients

📄 Ask a Doctor Before Use If 22 words ▾

Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose.

📄 When Using This Product 17 words ▾

When using this product do not take more than directed. Taking more than directed may cause drowsiness.

📄 Stop Use and Ask a Doctor If 19 words ▾

Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 22 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

📄 Questions or Comments 12 words ▾

Questions or comments? Call 833-358-6431 Monday to Friday 9:00am to 7:00pm EST

📄 Package Label / Principal Display Panel 69 words ▾

Principal Display Panel COMPARE TO CHILDREN’S CLARITIN ® CHEWABLES ACTIVE INGREDIENT Foster & Thrive™ Children’s Allergy Relief Loratadine Chewable Tablets, 5 mg ANTIHISTAMINE 2 Years and Older | Non-Drowsy** | 24 Hour Indoor & Outdoor Allergies GRAPE FLAVOR ACTUAL SIZE Non-Drowsy** Relief of: • Sneezing • Runny Nose • Itchy, Watery Eyes • Itchy Throat or Nose **When Taken As Directed. See Drug Facts Panel. 30 CHEWABLE TABLETS 3y8-km-childrens-allergy-relief

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
4.6K
Units reimbursed last 4 qtrs
153.9K
Gross reimbursed last 4 qtrs
$91.2K
Avg / prescription
$19.86
Avg / unit
$0.5926
Latest quarter Q1 2026
958Rx
Medicaid pays / ea
$0.5926
gross reimbursed
vs
NADAC / ea
$0.5212
acquisition cost
=
Spread
+$0.0714
+14% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
30% FFS 70% MCO
Fee-for-service · 1,362 Rx Managed care · 3,230 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 5,708 units · 99.5 per 100k residents MN Wisconsin: no data reported WI Michigan: 18,143 units · 181 per 100k residents MI New York: no data reported NY Vermont: 1,380 units · 213 per 100k residents VT New Hampshire: 1,950 units · 139 per 100k residents NH Oregon: no data reported OR Nevada: 455 units · 14.2 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: 540 units · 4.3 per 100k residents IL Indiana: 2,324 units · 33.9 per 100k residents IN Ohio: 480 units · 4.1 per 100k residents OH Pennsylvania: 13,744 units · 106 per 100k residents PA New Jersey: 390 units · 4.2 per 100k residents NJ Massachusetts: no data reported MA California: 33,726 units · 86.6 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: no data reported MO Kentucky: 29,848 units · 659 per 100k residents KY West Virginia: 6,720 units · 380 per 100k residents WV Virginia: 3,780 units · 43.4 per 100k residents VA Maryland: 792 units · 12.8 per 100k residents MD Connecticut: 366 units · 10.1 per 100k residents CT Rhode Island: no data reported RI Arizona: 6,013 units · 80.9 per 100k residents AZ New Mexico: no data reported NM Kansas: 4,547 units · 155 per 100k residents KS Arkansas: no data reported AR Tennessee: 1,500 units · 21.0 per 100k residents TN North Carolina: no data reported NC South Carolina: 8,421 units · 157 per 100k residents SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: 4,935 units · 168 per 100k residents MS Alabama: 5,005 units · 98.0 per 100k residents AL Georgia: 3,090 units · 28.0 per 100k residents GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
4.1659
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Kentucky 659 /100k
2 West Virginia 380 /100k
3 Vermont 213 /100k
4 Michigan 181 /100k
5 Mississippi 168 /100k
6 South Carolina 157 /100k
7 Kansas 155 /100k
8 New Hampshire 139 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.
← 70677-1042-01 · Strategic 70677-1047-01 · Strategic →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.